"10.1371_journal.pone.0061962","plos one","2013-04-16T00:00:00Z","Connor P O’Meara; Charles W Armitage; Marina C G Harvie; Peter Timms; Nils Y Lycke; Kenneth W Beagley","Institute of Health and Biomedical Innovation (IHBI), Queensland University of Technology (QUT), Brisbane, Queensland, Australia; Mucosal Immunobiology and Vaccine Centre (MIVAC), University of Göteborg, Göteborg, Götaland, Sweden","Conceived and designed the experiments: CPO PT NYL KWB. Performed the experiments: CPO CWA MSGH. Analyzed the data: CPO CWA MSGH PT NYL KWB. Contributed reagents/materials/analysis tools: NYL. Wrote the paper: CPO CWA MSGH PT NYL KWB.","This work was partly funded by Biovitrum, former owner of the exclusive licensing rights to CTA1-DD. Today the exclusive licensing rights to and ownership of CTA1-DD belongs to the inventors (Dr. Lycke and Dr Löwenadler) who have no commercial interests being explored. There are no patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.","2013","04","Connor P O’Meara","CPOM",6,TRUE,4,3,6,6,TRUE,TRUE,TRUE,1,"3",FALSE
